Once‐daily USL255 as adjunctive treatment of partial‐onset seizures: Randomized phase III study
2014
Objective
To evaluate the efficacy and safety of USL255, Qudexy™ XR (topiramate) extended-release capsules, as an adjunctive treatment for refractory partial-onset seizures (POS) in adults taking one to three concomitant antiepileptic drugs.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
33
References
27
Citations
NaN
KQI